Our work is significant because it raises the possibility of new strategies to increase CFTR, leading to new therapies for cystic fibrosis in which dexamethasone is likely to change the balance between HSP70 and HSP90 in such a way as to promote maturation of newly synthesized CFTR, as we have shown here. The gene discussed is CFTR; the disease is cystic fibrosis.